Showing results (21-30 of 5,223) with videos related to
Sort By:
Pageof 523
Psychiatry Research|February 25, 2026
Sigma-1 receptor antagonism as a potential mechanism of sertraline-associated Alice in Wonderland syndromeKenji HashimotoMolecular Psychiatry|July 4, 2023
Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein-Barr virus and the gut-brain axisKenji HashimotoPsychiatry and Clinical Neurosciences|June 20, 2019
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspectiveKenji HashimotoThe Open Medicinal Chemistry Journal|January 22, 2011
Glycine transport inhibitors for the treatment of schizophreniaKenji HashimotoProgress in Neuro-Psychopharmacology & Biological Psychiatry|July 6, 2010
The role of glutamate on the action of antidepressantsKenji HashimotoCNS & Neurological Disorders Drug Targets|August 26, 2009
Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?Kenji HashimotoCancers|June 2, 2021
CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug DevelopmentKenji HashimotoExpert Opinion on Therapeutic Targets|June 27, 2014
Targeting of NMDA receptors in new treatments for schizophreniaKenji HashimotoBioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 18, 2007
BDNF variant linked to anxiety-related behaviorsKenji HashimotoPageof 523